Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Medical Equipment Industry Analysis

UpdatedJan 30, 2026
DataAggregated Company Financials
Companies53
  • 7D-3.8%
  • 3M-6.3%
  • 1Y-24.7%
  • YTD-5.0%

Over the last 7 days, the Medical Equipment industry has dropped 3.8%, driven by a pullback from Getinge of 7.0%. The industry has fallen 25% in the last year. Earnings are forecast to grow by 23% annually.

Industry Valuation and Performance

Has the Swedish Medical Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 30 Jan 2026SEK 138.9bSEK 76.6bSEK 2.1b36x65.4x1.8x
Sun, 28 Dec 2025SEK 175.9bSEK 93.9bSEK 2.4b45.4x72.4x1.9x
Tue, 25 Nov 2025SEK 174.7bSEK 94.3bSEK 2.4b44.1x72.8x1.9x
Thu, 23 Oct 2025SEK 183.7bSEK 93.6bSEK 2.0b50.2x93.9x2x
Sat, 20 Sep 2025SEK 188.4bSEK 93.3bSEK 1.4b50.8x135x2x
Mon, 18 Aug 2025SEK 190.0bSEK 93.5bSEK 1.5b43.9x130.4x2x
Wed, 16 Jul 2025SEK 196.0bSEK 93.2bSEK 1.5b40.9x132.9x2.1x
Fri, 13 Jun 2025SEK 190.5bSEK 93.3bSEK 1.5b36.4x129.1x2x
Sun, 11 May 2025SEK 178.9bSEK 92.6bSEK 2.3b31x78.8x1.9x
Tue, 08 Apr 2025SEK 163.2bSEK 91.5bSEK 2.9b27.9x57.1x1.8x
Thu, 06 Mar 2025SEK 161.0bSEK 76.5bSEK 2.5b29.1x65.4x2.1x
Sat, 01 Feb 2025SEK 171.7bSEK 76.1bSEK 1.7b36x99.1x2.3x
Mon, 30 Dec 2024SEK 157.1bSEK 74.7bSEK 1.8b29x86.1x2.1x
Wed, 27 Nov 2024SEK 153.4bSEK 75.1bSEK 2.0b26.8x77x2x
Fri, 25 Oct 2024SEK 170.6bSEK 74.9bSEK 2.2b32.4x77.8x2.3x
Sun, 22 Sep 2024SEK 180.1bSEK 74.5bSEK 3.1b23.7x57.8x2.4x
Tue, 20 Aug 2024SEK 174.4bSEK 74.5bSEK 3.3b30.3x53x2.3x
Thu, 18 Jul 2024SEK 166.4bSEK 73.1bSEK 2.7b31.4x61.3x2.3x
Sat, 15 Jun 2024SEK 158.2bSEK 72.8bSEK 2.6b30.4x60x2.2x
Mon, 13 May 2024SEK 169.7bSEK 73.0bSEK 2.7b31.8x61.9x2.3x
Wed, 10 Apr 2024SEK 169.2bSEK 72.2bSEK 2.6b32.3x65.9x2.3x
Fri, 08 Mar 2024SEK 160.1bSEK 72.2bSEK 2.4b32.2x66.3x2.2x
Sun, 04 Feb 2024SEK 166.4bSEK 73.1bSEK 1.9b46.4x89.9x2.3x
Tue, 02 Jan 2024SEK 173.8bSEK 71.4bSEK 1.5b41x113.4x2.4x
Thu, 30 Nov 2023SEK 167.4bSEK 70.0bSEK 1.3b36.2x132.8x2.4x
Sat, 28 Oct 2023SEK 140.0bSEK 69.9bSEK 1.2b25.8x112.4x2x
Mon, 25 Sep 2023SEK 150.3bSEK 68.8bSEK 1.1b31.3x140.6x2.2x
Wed, 23 Aug 2023SEK 153.5bSEK 68.2bSEK 828.8m30.8x185.2x2.3x
Fri, 21 Jul 2023SEK 161.3bSEK 68.2bSEK 281.7m34.3x572.7x2.4x
Sun, 18 Jun 2023SEK 179.9bSEK 67.0bSEK 1.3b34.3x133.9x2.7x
Tue, 16 May 2023SEK 181.1bSEK 65.8bSEK 1.4b37.6x128.4x2.8x
Thu, 13 Apr 2023SEK 175.9bSEK 64.1bSEK 1.4b36.7x129.3x2.7x
Sat, 11 Mar 2023SEK 166.4bSEK 64.1bSEK 1.4b37.9x116.3x2.6x
Mon, 06 Feb 2023SEK 183.7bSEK 62.7bSEK 2.0b33.3x92.8x2.9x
Price to Earnings Ratio

92.8x


Total Market Cap: SEK 183.7bTotal Earnings: SEK 2.0bTotal Revenue: SEK 62.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Medical Equipment Industry Price to Earnings3Y Average 98.5x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Medical Equipment industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 65.4x which is lower than its 3-year average PE of 98.5x.
  • The 3-year average PS ratio of 2.2x is higher than the industry's current PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Medical Equipment industry have grown 2.4% per year over the last three years.
  • Revenues for these companies have grown 6.9% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market-0.32%
Healthcare-1.45%
Medical Equipment-3.75%
Medical Supplies-1.94%
Medical Equipment-4.12%
Industry PE
  • Investors are most optimistic about the Medical Supplies industry which is trading above its 3-year average PE ratio.
    • Analysts are expecting annual earnings growth of 47.6%, which is lower than the prior year's growth of 9,226.8% per year.
  • Investors are most pessimistic about the Medical Equipment industry, which is trading below its 3-year average of 79.8x.
Forecasted Growth
  • Analysts are most optimistic on the Medical Supplies industry, expecting annual earnings growth of 48% over the next 5 years.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 18% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
IMP A SDB ImplanticaSEK 49.402.9%
+SEK 396.6m		23.5%PS667.6x
XVIVO Xvivo PerfusionSEK 236.205.4%
+SEK 384.3m		-49.7%PE295.7x
HEART Scandinavian Real HeartSEK 14.301.1%
+SEK 50.8m		-53.3%PS62963x
2CUREX 2cureXSEK 2.65100.8%
+SEK 33.4m		477.3%n/a
NOSA Nosa PlugsSEK 0.6222.5%
+SEK 29.7m		-35.1%PS9.2x

Latest News

XVIVO
SEK 236.20
Xvivo Perfusion
7D
5.4%
1Y
-49.7%

Xvivo Perfusion AB (publ) Just Beat EPS By 134%: Here's What Analysts Think Will Happen Next

Jan 30
Xvivo Perfusion AB (publ) Just Beat EPS By 134%: Here's What Analysts Think Will Happen Next
GETI B
SEK 196.35
Getinge
7D
-7.0%
1Y
-10.3%

Getinge AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models

Jan 30
Getinge AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models
HEART
SEK 14.30
Scandinavian Real Heart
7D
1.1%
1Y
-53.3%
CEVI
SEK 150.00
CellaVision
7D
-4.8%
1Y
-32.4%
VIMIAN
SEK 27.26
Vimian Group
7D
-5.2%
1Y
-32.4%
EKTA B
SEK 58.95
Elekta
7D
-3.4%
1Y
-11.1%
CARE
SEK 24.90
Careium
7D
4.6%
1Y
-11.7%
ARJO B
SEK 29.84
Arjo
7D
-2.0%
1Y
-22.9%

ARJO B: Higher Future P/E Will Support Upside Despite Softer Assumptions

Analysts have reduced their price target on Arjo to $42.00, as they now assume more moderate revenue growth, slightly lower profit margins, a marginally higher discount rate, and a higher future P/E multiple in their models. Valuation Changes Fair Value: Unchanged at SEK 42.0 per share, reflecting the combined impact of all model adjustments.
BIOWKS
SEK 3.02
Bio-Works Technologies
7D
7.1%
1Y
224.7%
OSSD
SEK 9.20
OssDsign
7D
-8.7%
1Y
-8.4%

OSSD: New US Based Leadership Will Drive Future Orthobiologics Expansion

Analysts have kept their price target for OssDsign steady at €13.50, citing only marginal adjustments to the discount rate, revenue growth, profit margin and forward P/E assumptions that together are not enough to shift their overall valuation view. What's in the News OssDsign AB appointed Mark Waugh as CEO, effective January 1, 2026, following his senior roles at Smith & Nephew, Medtronic Sofamor Danek, and Medacta USA (company announcement).
IMP A SDB
SEK 49.40
Implantica
7D
2.9%
1Y
23.5%
SUS
SEK 27.24
Surgical Science Sweden
7D
-3.8%
1Y
-84.9%

SUS: Future Returns Will Balance Lost Partnership And New Growth Guidance

Analysts have kept their price target for Surgical Science Sweden steady at SEK 33.0. They point to small adjustments in the discount rate, expected revenue growth, profit margin and forward P/E assumptions as supporting factors rather than drivers of a new valuation level. What's in the News Surgical Science Sweden issued revenue guidance for 2027, with sales growth expected to be 10% to 15% per year for that period (Corporate guidance).
SEDANA
SEK 10.50
Sedana Medical
7D
1.9%
1Y
-44.3%
NOSA
SEK 0.62
Nosa Plugs
7D
22.5%
1Y
-35.1%
2CUREX
SEK 2.65
2cureX
7D
100.8%
1Y
477.3%
STIL
SEK 167.00
Stille
7D
-4.3%
1Y
-30.4%

Returns At Stille (STO:STIL) Are On The Way Up

Dec 23
Returns At Stille (STO:STIL) Are On The Way Up